Advertisement
U.S. Markets close in 2 hrs 19 mins

Galderma Group N (GALD.SW)

Swiss - Swiss Delayed Price. Currency in CHF
77.85-0.35 (-0.45%)
At close: 05:30PM CEST
Currency in CHF

Valuation Measures4

Market Cap (intraday) 18.58B
Enterprise Value 20.79B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 384.92
52 Week Low 353.00
50-Day Moving Average 379.76
200-Day Moving Average 373.36

Share Statistics

Avg Vol (3 month) 3646.38k
Avg Vol (10 day) 3197.43k
Shares Outstanding 5237.57M
Implied Shares Outstanding 6N/A
Float 850.96M
% Held by Insiders 161.21%
% Held by Institutions 111.06%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin -0.33%
Operating Margin (ttm)14.21%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)4.32B
Revenue Per Share (ttm)0.76
Quarterly Revenue Growth (yoy)10.00%
Gross Profit (ttm)N/A
EBITDA 841.9M
Net Income Avi to Common (ttm)-14.2M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)1,075.00%

Balance Sheet

Total Cash (mrq)385M
Total Cash Per Share (mrq)1.62
Total Debt (mrq)2.95B
Total Debt/Equity (mrq)38.61
Current Ratio (mrq)1.20
Book Value Per Share (mrq)32.13

Cash Flow Statement

Operating Cash Flow (ttm)419.4M
Levered Free Cash Flow (ttm)N/A